The MECP2 Consortium is a dynamic collaboration between the laboratories of three distinguished scientists, Adrian Bird, Michael Greenberg and Gail Mandel.

Reference: MECP2 Consortium Abstract: n.a Made possible by a $1 million gift by RSRT Trustee Anthony Schoener and his wife Kathy, the Consortium was formed to definitively determine how this complex protein, MeCP2, functions and exerts its powerful influence on the human brain. Deep knowledge of its structure and roles in neurological development and maintenance … Read more

A research Consortium to define the function of MeCP2: A step towards the development of therapeutics for treating Rett Syndrome

Reference: Adrian Bird Abstract: n.a PROJECT DETAILS  beginning: 2011. end: 2014. Country of research: United Kingdom Counry of funding source: United States Funding organization: Rett Syndrome Research Trust Financing: PRIVATE FUNDERS – 442 254 € hyperlink

Pharmacological treatment of respiratory disorders in a mouse model of Rett syndrome

Reference: Paton, Julian Abstract: Breathing abnormalities consisting of rapid deep respiration followed by cessation of breathing and an irregular interval between breaths are a common and distressing feature of Rett syndrome (RTT). Using a mouse model we have shown that injections of a compound that boosts the brain concentration of the inhibitory neurotransmitter ? amino-butyric … Read more

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close